The risk of paradoxical levetiracetam effect is increased in mentally retarded patients

A. Szűcs, Z. Clemens, R. Jakus, G. Rásonyi, Daniel Fabó, András Holló, Gábor Barcs, A. Kelemen, J. Janszky

Research output: Article

18 Citations (Scopus)

Abstract

Purpose: Incidental paradoxical antiepileptic effect of levetiracetam has been described. The aim of the present study was to identify the epilepsy patients at risk. Methods: We performed a retrospective analysis in 207 patients treated with levetiracetam. This entailed evaluation of patient notes and patient interviews. A paradoxical effect was defined as an increased seizure frequency or the experience of more severe seizures including generalized tonic-clonic seizures (GTCS) within 1 month after starting levetiracetam (LEV). Results: Thirty patients (14%) experienced a paradoxical effect. Eight of them (4%) developed de novo GTCS. We could not demonstrate any association between the paradoxical effect of levetiracetam and type of epilepsy or the antiepileptic comedication used. However we found that the paradoxical effect developed preferentially (p <0.001) in mentally retarded patients. Conclusion: Because there is an increased risk of worsening epilepsy when starting levetiracetam treatment of mentally retarded epileptic patients, there is a need for caution and close observation during the first weeks of therapy.

Original languageEnglish
Pages (from-to)1174-1179
Number of pages6
JournalEpilepsia
Volume49
Issue number7
DOIs
Publication statusPublished - júl. 2008

Fingerprint

etiracetam
Mentally Disabled Persons
Seizures
Epilepsy
Anticonvulsants

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

The risk of paradoxical levetiracetam effect is increased in mentally retarded patients. / Szűcs, A.; Clemens, Z.; Jakus, R.; Rásonyi, G.; Fabó, Daniel; Holló, András; Barcs, Gábor; Kelemen, A.; Janszky, J.

In: Epilepsia, Vol. 49, No. 7, 07.2008, p. 1174-1179.

Research output: Article

@article{09c5d442314049b7a78ce1cb5ca57353,
title = "The risk of paradoxical levetiracetam effect is increased in mentally retarded patients",
abstract = "Purpose: Incidental paradoxical antiepileptic effect of levetiracetam has been described. The aim of the present study was to identify the epilepsy patients at risk. Methods: We performed a retrospective analysis in 207 patients treated with levetiracetam. This entailed evaluation of patient notes and patient interviews. A paradoxical effect was defined as an increased seizure frequency or the experience of more severe seizures including generalized tonic-clonic seizures (GTCS) within 1 month after starting levetiracetam (LEV). Results: Thirty patients (14{\%}) experienced a paradoxical effect. Eight of them (4{\%}) developed de novo GTCS. We could not demonstrate any association between the paradoxical effect of levetiracetam and type of epilepsy or the antiepileptic comedication used. However we found that the paradoxical effect developed preferentially (p <0.001) in mentally retarded patients. Conclusion: Because there is an increased risk of worsening epilepsy when starting levetiracetam treatment of mentally retarded epileptic patients, there is a need for caution and close observation during the first weeks of therapy.",
keywords = "Antiepileptic, Inverse effect, Levetiracetam, Mental retardation, Paradoxical, Seizure-inducing",
author = "A. Szűcs and Z. Clemens and R. Jakus and G. R{\'a}sonyi and Daniel Fab{\'o} and Andr{\'a}s Holl{\'o} and G{\'a}bor Barcs and A. Kelemen and J. Janszky",
year = "2008",
month = "7",
doi = "10.1111/j.1528-1167.2008.01585.x",
language = "English",
volume = "49",
pages = "1174--1179",
journal = "Epilepsia",
issn = "0013-9580",
publisher = "Wiley-Blackwell",
number = "7",

}

TY - JOUR

T1 - The risk of paradoxical levetiracetam effect is increased in mentally retarded patients

AU - Szűcs, A.

AU - Clemens, Z.

AU - Jakus, R.

AU - Rásonyi, G.

AU - Fabó, Daniel

AU - Holló, András

AU - Barcs, Gábor

AU - Kelemen, A.

AU - Janszky, J.

PY - 2008/7

Y1 - 2008/7

N2 - Purpose: Incidental paradoxical antiepileptic effect of levetiracetam has been described. The aim of the present study was to identify the epilepsy patients at risk. Methods: We performed a retrospective analysis in 207 patients treated with levetiracetam. This entailed evaluation of patient notes and patient interviews. A paradoxical effect was defined as an increased seizure frequency or the experience of more severe seizures including generalized tonic-clonic seizures (GTCS) within 1 month after starting levetiracetam (LEV). Results: Thirty patients (14%) experienced a paradoxical effect. Eight of them (4%) developed de novo GTCS. We could not demonstrate any association between the paradoxical effect of levetiracetam and type of epilepsy or the antiepileptic comedication used. However we found that the paradoxical effect developed preferentially (p <0.001) in mentally retarded patients. Conclusion: Because there is an increased risk of worsening epilepsy when starting levetiracetam treatment of mentally retarded epileptic patients, there is a need for caution and close observation during the first weeks of therapy.

AB - Purpose: Incidental paradoxical antiepileptic effect of levetiracetam has been described. The aim of the present study was to identify the epilepsy patients at risk. Methods: We performed a retrospective analysis in 207 patients treated with levetiracetam. This entailed evaluation of patient notes and patient interviews. A paradoxical effect was defined as an increased seizure frequency or the experience of more severe seizures including generalized tonic-clonic seizures (GTCS) within 1 month after starting levetiracetam (LEV). Results: Thirty patients (14%) experienced a paradoxical effect. Eight of them (4%) developed de novo GTCS. We could not demonstrate any association between the paradoxical effect of levetiracetam and type of epilepsy or the antiepileptic comedication used. However we found that the paradoxical effect developed preferentially (p <0.001) in mentally retarded patients. Conclusion: Because there is an increased risk of worsening epilepsy when starting levetiracetam treatment of mentally retarded epileptic patients, there is a need for caution and close observation during the first weeks of therapy.

KW - Antiepileptic

KW - Inverse effect

KW - Levetiracetam

KW - Mental retardation

KW - Paradoxical

KW - Seizure-inducing

UR - http://www.scopus.com/inward/record.url?scp=47249161136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=47249161136&partnerID=8YFLogxK

U2 - 10.1111/j.1528-1167.2008.01585.x

DO - 10.1111/j.1528-1167.2008.01585.x

M3 - Article

C2 - 18479387

AN - SCOPUS:47249161136

VL - 49

SP - 1174

EP - 1179

JO - Epilepsia

JF - Epilepsia

SN - 0013-9580

IS - 7

ER -